Cargando…

Semaphorin 3A: A potential target for prevention and treatment of nickel allergy

Metal allergy is one of the typical immune disorders encountered during the application of dental/medical materials and has a highly complex pathogenic mechanism. Semaphorin 3A (Sema3A), a member of the semaphorin family, is reported to be involved in various immune disorders. However, its role in m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Lipei, Watanabe, Megumi, Minami, Norikazu, Yunizar, Mohammad Fadyl, Ichikawa, Tetsuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262932/ https://www.ncbi.nlm.nih.gov/pubmed/35798870 http://dx.doi.org/10.1038/s42003-022-03641-0

Ejemplares similares

Metal Allergy Mediates the Development of Oral Lichen Planus via TSLP-TSLPR Signaling
por: Yunizar, Mohammad Fadyl, et al.
Publicado: (2022)

Are Allergy-Induced Implant Failures Actually Hypersensitivity Reactions to Titanium? A Literature Review
por: Watanabe, Megumi, et al.
Publicado: (2023)

A Novel DC Therapy with Manipulation of MKK6 Gene on Nickel Allergy in Mice
por: Watanabe, Megumi, et al.
Publicado: (2011)

Robotics in Dentistry: A Narrative Review
por: Liu, Lipei, et al.
Publicado: (2023)

Hardness, Cohesiveness, and Adhesiveness of Oral Moisturizers and Denture Adhesives: Selection Criteria for Denture Wearers
por: Fujimoto, Keiko, et al.
Publicado: (2016)

Semaphorins as Potential Immune Therapeutic Targets for Cancer
por: Jiang, Jun, et al.
Publicado: (2022)

Semaphorin-3 Promotes Specific Immunotherapy Effects on Experimental Food Allergy
por: Huang, Huang, et al.
Publicado: (2022)

Semaphorin 3A: A Potential Target for Low Back Pain
por: Yin, Pengbin, et al.
Publicado: (2015)

Systemic nickel allergy syndrome
por: Da Mata Perez, Luciana, et al.
Publicado: (2015)

Molecular Mechanisms of Nickel Allergy
por: Saito, Masako, et al.
Publicado: (2016)

Nickel allergy in relationship to previous oral and cutaneous nickel contact.
por: Todd, D. J., et al.
Publicado: (1989)

Nickel oral hyposensitization in patients with systemic nickel allergy syndrome
por: Di Gioacchino, Mario, et al.
Publicado: (2014)

The semaphorins
por: Yazdani, Umar, et al.
Publicado: (2006)

Patellofemoral Joint Replacement and Nickel Allergy: An Unusual Presentation
por: Syed, Farhan, et al.
Publicado: (2015)

Secreted Human Amyloid Precursor Protein Binds Semaphorin 3a and Prevents Semaphorin-Induced Growth Cone Collapse
por: Magdesian, Margaret H., et al.
Publicado: (2011)

Semaphorins in Angiogenesis and Autoimmune Diseases: Therapeutic Targets?
por: Iragavarapu-Charyulu, Vijaya, et al.
Publicado: (2020)

Irritable Bowel Syndrome and Nickel Allergy: What Is the Role of the Low Nickel Diet?
por: Rizzi, Angela, et al.
Publicado: (2017)

Impact of nickel oral hyposensitization on quality of life in systemic nickel allergy syndrome
por: Rizzi, Angela, et al.
Publicado: (2020)

Use of a Polyetheretherketone Clasp Retainer for Removable Partial Denture: A Case Report
por: Ichikawa, Tetsuo, et al.
Publicado: (2019)

Semaphorin 7A as a potential immune regulator and promising therapeutic target in rheumatoid arthritis
por: Xie, Jianmin, et al.
Publicado: (2017)

Systemic nickel allergy syndrome. Biological monitoring of dietary nickel intake and induction of immunotolerance
por: Angelo Mario, Cirla
Publicado: (2011)

A method to visualize transdermal nickel permeation in mouse skin using a nickel allergy patch
por: Sugiyama, Tomoko, et al.
Publicado: (2015)

Semaphorins as emerging clinical biomarkers and therapeutic targets in cancer
por: Mastrantonio, Roberta, et al.
Publicado: (2021)

Nickel allergy is associated with a broad spectrum cytokine response
por: De Graaf, Niels P. J., et al.
Publicado: (2022)

Management of contact dermatitis due to nickel allergy: an update
por: Torres, Fernanda, et al.
Publicado: (2009)

Semaphorins—not just for axons
por: LeBrasseur, Nicole
Publicado: (2002)

Semaphorin3A: A Potential Therapeutic Tool for Lupus Nephritis
por: Bejar, Jacob, et al.
Publicado: (2018)

Mutational Spectrum of Semaphorin 3A and Semaphorin 3D Genes in Spanish Hirschsprung patients
por: Luzón-Toro, Berta, et al.
Publicado: (2013)

Semaphorin 3C as a Therapeutic Target in Prostate and Other Cancers
por: Hui, Daniel H.F., et al.
Publicado: (2019)

Semaphorin 3A—Glycosaminoglycans Interaction as Therapeutic Target for Axonal Regeneration
por: Pérez, Yolanda, et al.
Publicado: (2021)

Expression of Semaphorin 4A and its potential role in rheumatoid arthritis
por: Wang, Lin, et al.
Publicado: (2015)

Overexpression of Semaphorin-3A and Semaphorin-4D in the Peripheral Blood from Newly Diagnosed Patients with Chronic Lymphocytic Leukemia
por: Parsa, Somayeh, et al.
Publicado: (2019)

Exploiting pleiotropic activities of semaphorins as multi-target therapies for cancer
por: Moserle, Lidia, et al.
Publicado: (2012)

Current drug design to target the Semaphorin/Neuropilin/Plexin complexes
por: Meyer, Lionel A. T., et al.
Publicado: (2016)

Targeting Semaphorin 3C in Prostate Cancer With Small Molecules
por: Lee, Chung C W, et al.
Publicado: (2018)

The Role of Semaphorins and Their Receptors in Gliomas
por: Law, Janice Wai Sze, et al.
Publicado: (2012)

Semaphorins and Their Receptors in Hematological Malignancies
por: Wei, Li, et al.
Publicado: (2019)

The Role of Semaphorins in Metabolic Disorders
por: Lu, Qiongyu, et al.
Publicado: (2020)

Role of Semaphorins in Ischemic Stroke
por: Du, Huaping, et al.
Publicado: (2022)

Semaphorin 3A, a potential immune regulator in Familial Mediterranean Fever
por: Rimar, D, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_m9d391skq9i9dd16j2semrhbfr